Regulation and expression of the ATP-binding cassette transporter ABCG2 in human embryonic stem cells

Stem Cells

Volumn 30, Issue 10, 2012, Pages 2175-2187

  Padmanabhan, Raji ^a   Chen, Kevin G ^b   Gillet, Jean Pierre ^a   Handley, Misty ^a   Mallon, Barbara S ^b   Hamilton, Rebecca S ^b   Park, Kyeyoon ^b   Varma, Sudhir ^c   Mehaffey, Michele G ^e   Robey, Pamela G ^b,d   Mckay, Ronald D G ^b   Gottesman, Michael M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c National Institute of Allergy and Infectious Diseases   (United States)

^d NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^e FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

Author keywords

ABCG2; ATP binding cassette; BMP 4; Differentiation; Human embryonic stem cells

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; BREAST CANCER RESISTANCE PROTEIN; FIBROBLAST GROWTH FACTOR 2; MESSENGER RNA; STAGE SPECIFIC EMBRYO ANTIGEN 1;

ARTICLE; CELL DIFFERENTIATION; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; EMBRYO; EMBRYOID BODY; EMBRYONIC STEM CELL; FLOW CYTOMETRY; GENOME ANALYSIS; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; NORTHERN BLOTTING; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA SEQUENCE; SIGNAL TRANSDUCTION; TRANSLATION REGULATION; WESTERN BLOTTING;

ANIMALS; ANTIGENS, CD15; ATP-BINDING CASSETTE TRANSPORTERS; BONE MORPHOGENETIC PROTEIN 4; CELL DIFFERENTIATION; CELLS, CULTURED; EMBRYONIC STEM CELLS; FEEDER CELLS; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; MICE; MICRORNAS; NEOPLASM PROTEINS; PROTEIN BIOSYNTHESIS; RNA, MESSENGER; TRANSFECTION;

EID: 84866704415     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.1195     Document Type: Article

References (33)

1. Deeley RG, Westlake C, Cole SP. Transmembrane transport of endoand xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins. Physiol Rev 2006;86:849-899.
2. Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: Role of ATP-dependent transporters. Nat Rev Cancer 2002;2:48-58.
3. Krishnamurthy P, Schuetz JD. Role of ABCG2/BCRP in biology and medicine. Annu Rev Pharmacol Toxicol 2006;46:381-410.
4. Jonker JW, Buitelaar M, Wagenaar E et al. The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria. Proc Natl Acad Sci USA 2002;99:15649-15654.
5. Evseenko DA, Paxton JW, Keelan JA. Independent regulation of apical and basolateral drug transporter expression and function in placental trophoblasts by cytokines, steroids, and growth factors. Drug Metab Dispos 2007;35:595-601.
6. Islam MO, Kanemura Y, Tajria J et al. Functional expression of ABCG2 transporter in human neural stem/progenitor cells. Neurosci Res 2005;52:75-82.
7. Kim M, Turnquist H, Jackson J et al. The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells. Clin Cancer Res 2002;8:22-28.
8. Scharenberg CW, Harkey MA, Torok-Storb B. The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood 2002;99:507-512.
9. Zhou S, Schuetz JD, Bunting KD et al. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med 2001;7:1028-1034.
10. Klimanskaya I, Chung Y, Meisner L et al. Human embryonic stem cells derived without feeder cells. Lancet 2005;365:1636-1641.
11. Mallon BS, Park KY, Chen KG et al. Toward xeno-free culture of human embryonic stem cells. Int J Biochem Cell Biol 2006;38:1063-1075.
12. Thomson JA, Itskovitz-Eldor J, Shapiro SS et al. Embryonic stem cell lines derived from human blastocysts. Science 1998;282:1145-1147.
13. Xu C, Inokuma MS, Denham J et al. Feeder-free growth of undifferentiated human embryonic stem cells. Nat Biotechnol 2001;19:971-974.
14. Apati A, Orban TI, Varga N et al. High level functional expression of the ABCG2 multidrug transporter in undifferentiated human embryonic stem cells. Biochim Biophys Acta 2008;1778:2700-2709.
15. Sarkadi B, Orban TI, Szakacs G et al. Evaluation of ABCG2 expression in human embryonic stem cells: Crossing the same river twice? Stem Cells 2010;28:174-176.
16. Zeng H, Park JW, Guo M et al. Lack of ABCG2 expression and side population properties in human pluripotent stem cells. Stem Cells 2009;27:2435-2445.
17. Robey RW, Honjo Y, van de Laar A et al. A functional assay for detection of the mitoxantrone resistance protein, Mxr (ABCG2). Biochim Biophys Acta 2001;1512:171-182.
18. Nakagawa M, Schneider E, Dixon KH et al. Reduced intracellular drug accumulation in the absence of P-glycoprotein (mdr1) overexpression in mitoxantrone-resistant human MCF-7 breast cancer cells. Cancer Res 1992;52:6175-6181.
19. Orina JN, Calcagno AM, Wu CP et al. Evaluation of current methods used to analyze the expression profiles of ATP-binding cassette transporters yields an improved drug-discovery database. Mol Cancer Ther 2009;8:2057-2066.
20. Trapnell C, Pachter L, Salzberg SL. TopHat: Discovering splice junctions with RNA-Seq. Bioinformatics (Oxford, England) 2009;25:1105-1111.
21. Trapnell C, Williams BA, Pertea G et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nature Biotechnol 2010;28:511-515.
22. Chen KG, Leapman RD, Zhang G et al. Influence of melanosome dynamics on melanoma drug sensitivity. J Natl Cancer Inst 2009;101:1259-1271.
23. Wozney JM, Rosen V, Celeste AJ et al. Novel regulators of bone formation: Molecular clones and activities. Science 1988;242:1528-1534.
24. To KK, Robey RW, Knutsen T et al. Escape from hsa-miR-519c enables drug-resistant cells to maintain high expression of ABCG2. Mol Cancer Ther 2009;8:2959-2968.
25. To KK, Zhan Z, Litman T et al. Regulation of ABCG2 expression at the 30 untranslated region of its mRNA through modulation of transcript stability and protein translation by a putative microRNA in the S1 colon cancer cell line. Mol Cell Biol 2008;28:5147-5161.
26. Ying QL, Nichols J, Chambers I et al. BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell selfrenewal in collaboration with STAT3. Cell 2003;115:281-292.
27. Xu Y, Zhu X, Hahm HS et al. Revealing a core signaling regulatory mechanism for pluripotent stem cell survival and self-renewal by small molecules. Proc Natl Acad Sci USA 2010;107:8129-8134.
28. Yanes O, Clark J, Wong DM et al. Metabolic oxidation regulates embryonic stem cell differentiation. Nat Chem Biol 2010;6:411-417.
29. Martin CM, Ferdous A, Gallardo T et al. Hypoxia-inducible factor- 2alpha transactivates Abcg2 and promotes cytoprotection in cardiac side population cells. Circ Res 2008;102:1075-1081.
30. Susanto J, Lin YH, Chen YN et al. Porphyrin homeostasis maintained by ABCG2 regulates self-renewal of embryonic stem cells. PLoS One 2008;3:e4023.
31. Chen G, Jaffrezou JP, Fleming WH et al. Prevalence of multidrug resistance related to activation of the mdr1 gene in human sarcoma mutants derived by single-step doxorubicin selection. Cancer Res 1994;54:4980-4987.
32. Jaffrezou JP, Chen G, Duran GE et al. Mutation rates and mechanisms of resistance to etoposide determined from fluctuation analysis. J Natl Cancer Inst 1994;86:1152-1158.
33. Calcagno AM, Fostel JM, To KK et al. Single-step doxorubicinselected cancer cells overexpress the ABCG2 drug transporter through epigenetic changes. Br J Cancer 2008;98:1515-1524.